MarketCap
Facebook
X
Telegram
Conformis EPS Ratio | CFMS
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio Conformis
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.99 | -0.36 | -0.34 | -0.44 | -0.74 | -1.24 | -1.39 | -2.6 | -10.8 | -12 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.34 | -12 | -3.69 |
Quarterly EPS Ratio Conformis
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.78 | -1.32 | - | -0.08 | -0.09 | -0.09 | - | -0.07 | 0.21 | -0.09 | -0.08 | -0.09 | -0.03 | -0.14 | -0.08 | -0.13 | -0.11 | -0.12 | -0.16 | -0.12 | -0.24 | -0.22 | -0.27 | -0.29 | -0.28 | -0.4 | -0.37 | -0.31 | -0.34 | -0.37 | -0.37 | -0.45 | -2.51 | -3.32 | -2.83 | -2.44 | -2.49 | -3.04 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.21 | -3.32 | -0.692 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Medical devices industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Second Sight Medical Products
EYES
|
-0.43 | - | -0.97 % | $ 54.4 M |  USA |
 |
EDAP TMS S.A.
EDAP
|
-0.51 | - | - | $ 162 M |  France |
 |
Aziyo Biologics
AZYO
|
1.29 | - | 1.37 % | $ 20.5 M | USA |
 |
AxoGen
AXGN
|
-0.34 | $ 48.73 | 1.42 % | $ 2.24 B | USA |
 |
Allied Healthcare Products
AHPI
|
-0.48 | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
-9.65 | - | 37.08 % | $ 85.7 M | USA |
 |
Apollo Endosurgery
APEN
|
-0.98 | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
-23.3 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-0.12 | - | - | $ 3.31 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
-6.74 | $ 18.34 | 0.55 % | $ 1.41 B | USA |
 |
BIOLASE
BIOL
|
-29.4 | - | -13.19 % | $ 166 K | USA |
 |
IRIDEX Corporation
IRIX
|
-0.26 | $ 0.86 | 3.87 % | $ 14.6 M | USA |
 |
Dynatronics Corporation
DYNT
|
-1.43 | - | 14.99 % | $ 929 K | USA |
 |
Cardiovascular Systems
CSII
|
-0.94 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-2.87 | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
-39.7 | - | - | $ 10.2 M | USA |
 |
GBS
GBS
|
-2 | - | -0.57 % | $ 7.12 M | USA |
 |
LivaNova PLC
LIVN
|
-4.45 | $ 82.22 | 0.02 % | $ 4.48 B |  Britain |
 |
LENSAR
LNSR
|
-2.87 | $ 8.2 | 0.24 % | $ 98.1 M | USA |
 |
Avanos Medical
AVNS
|
-1.57 | $ 24.99 | - | $ 1.16 B | USA |
 |
Invacare Corporation
IVC
|
-0.54 | - | - | $ 24.7 M | USA |
 |
MiMedx Group
MDXG
|
0.33 | $ 4.27 | 1.67 % | $ 631 M | USA |
 |
ClearPoint Neuro
CLPT
|
-0.9 | $ 15.34 | 0.1 % | $ 434 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-0.13 | $ 0.4 | 10.38 % | $ 24.9 M | USA |
 |
SmileDirectClub
SDC
|
-0.71 | - | -53.45 % | $ 9.71 M | USA |
 |
Sientra
SIEN
|
-2.23 | - | -16.59 % | $ 10.3 M | USA |
 |
Silk Road Medical, Inc
SILK
|
-1.44 | - | - | $ 1.07 B | USA |
 |
NanoVibronix
NAOV
|
-26.7 | - | - | $ 1.08 M | USA |
 |
Surgalign Holdings
SRGA
|
-8.33 | - | -32.98 % | $ 1.68 M | USA |
 |
ShockWave Medical
SWAV
|
4.01 | - | - | $ 12.3 B | USA |
 |
Inogen
INGN
|
-0.86 | $ 5.75 | 0.17 % | $ 153 M | USA |
 |
NuVasive
NUVA
|
0.78 | - | - | $ 2.07 B | USA |
 |
Natus Medical Incorporated
NTUS
|
0.39 | - | 1.94 % | $ 1.05 B | USA |
 |
Nevro Corp.
NVRO
|
-3.06 | - | - | $ 217 M | USA |
 |
ThermoGenesis Holdings
THMO
|
-7.59 | - | -25.84 % | $ 171 K | USA |
 |
Talis Biomedical Corporation
TLIS
|
-34.1 | - | 3.55 % | $ 7.96 M | USA |
 |
Butterfly Network
BFLY
|
-0.31 | $ 8.84 | 0.79 % | $ 2.18 B | USA |
 |
Vapotherm
VAPO
|
-9.64 | - | 6.72 % | $ 34 M | USA |